Temporal dynamics of clonal evolution in chronic lymphocytic leukemia with stereotyped IGHV4-34/IGKV2-30 antigen receptors: Longitudinal immunogenetic evidence

Molecular Medicine

Volumn 19, Issue 1, 2013, Pages 230-236

  Sutton, Lesley Ann ^a   Kostareli, Efterpi ^b   Stalika, Evangelia ^b,c   Tsaftaris, Athanasios ^c   Anagnostopoulos, Achilles ^b   Darzentas, Nikos ^c,d   Rosenquist, Richard ^a   Stamatopoulos, Kostas ^b,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b Hematology Department and HCT Unit   (Greece)

^c INFORMATION TECHNOLOGIES INSTITUTE   (Greece)

^d MASARYK UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLONAL EVOLUTION; GENE; GENE SEQUENCE; HUMAN; IMMUNOGENETICS; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOGLOBULIN KAPPA CHAIN GENE; LONGITUDINAL STUDY; PRIORITY JOURNAL; SOMATIC HYPERMUTATION;

CLONAL EVOLUTION; HUMANS; IMMUNOGENETIC PHENOMENA; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN KAPPA-CHAINS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; RECEPTORS, ANTIGEN, B-CELL;

EID: 84882992722     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2013.00042     Document Type: Article

References (58)

1. Schroeder HW Jr, Dighiero G. (1994) The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol. Today. 15:288-94.
2. Hashimoto S, et al. (1995) Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. J. Exp. Med. 181:1507-17.
3. Efremov DG, et al. (1996) Restricted immunoglobulin VH region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia. Blood. 87:3869-76.
4. Johnson TA, Rassenti LZ, Kipps TJ. (1997) Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J. Immunol. 158:235-46.
5. Fais F, et al. (1998) Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J. Clin. Invest. 102:1515-25.
6. Chiorazzi N, Ferrarini M. (2003) B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu. Rev. Immunol. 21:841-94.
7. Damle RN, et al. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 94:1840-7.
8. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 94:1848-54.
9. Tobin G, et al. (2003) Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood. 101:4952-7.
10. Ghiotto F, et al. (2004) Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J. Clin. Invest. 113:1008-16.
11. Widhopf GF 2nd, et al. (2004) Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood. 104:2499-504.
12. Messmer BT, et al. (2004) Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J. Exp. Med. 200:519-25.
13. Tobin G, et al. (2004) Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood. 104:2879-85.
14. Ghia P, et al. (2005) Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood. 105:78-1685.
15. Thorselius M, et al. (2006) Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status. Blood. 107:2889-94.
16. Stamatopoulos K, et al. (2007) Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood. 109:259-70.
17. Murray F, et al. (2008) Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood. 111:1524-33.
18. Darzentas N, et al. (2010) A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence. Leukemia. 24:125-32.
19. Agathangelidis A, et al. (2012) Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. Blood. 119:4467-75.
20. Bomben R, et al. (2009) Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study. Br. J. Haematol. 144:492-506.
21. Tobin G, et al. (2002) Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood. 99:2262-4.
22. Strefford JC, et al. (2013) Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2. Leukemia. 2013, May 3 [Epub ahead of print].
23. Lanemo Myhrinder A, et al. (2008) A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood. 111:3838-48.
24. Catera R, et al. (2008) Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation. Mol. Med. 14:665-74.
25. Zwick C, et al. (2013) Autoantigenic targets of B-cell receptors derived from chronic lymphocytic leukemias bind to and induce proliferation of leukemic cells. Blood 121:4708-17.
26. Herve M, et al. (2005) Unmutated and mutated chronic lymphocytic leukemias derive from selfreactive B cell precursors despite expressing different antibody reactivity. J. Clin. Invest. 115:1636-43.
27. Chu CC, et al. (2008) Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA. Blood. 112:5122-9.
28. Chu CC, et al. (2010) Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin. Blood 115:3907-15.
29. Sutton LA, et al. (2009) Extensive intraclonal diversification in a subgroup of chronic lymphocytic leukemia patients with stereotyped IGHV4-34 receptors: implications for ongoing interactions with antigen. Blood. 114:4460-8.
30. Kostareli E, et al. (2010) Intraclonal diversification of immunoglobulin light chains in a subset of chronic lymphocytic leukemia alludes to antigendriven clonal evolution. Leukemia. 24:1317-24.
31. Hadzidimitriou A, et al. (2009) Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia. Blood. 113:403-11.
32. Hallek M, et al. (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 111:5446-56.
33. Lefranc MP, et al. (2009) IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res. 37:D1006-12.
34. Brochet X, Lefranc MP, Giudicelli V. (2008) IMGT/ V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 36:W503-8.
35. Krishnan MR, Jou NT, Marion TN. (1996) Correlation between the amino acid position of arginine in VH-CDR3 and specificity for native DNA among autoimmune antibodies. J. Immunol. 157:2430-9.
36. Li Z, Schettino EW, Padlan EA, Ikematsu H, Casali P. (2000) Structure-function analysis of a lupus anti-DNA autoantibody: central role of the heavy chain complementarity-determining region 3 Arg in binding of double-and singlestranded DNA. Eur. J. Immunol. 30:2015-26.
37. Jang YJ, Stollar BD. (2003) Anti-DNA antibodies: aspects of structure and pathogenicity. Cell Mol. Life Sci. 60:309-20.
38. Pugh-Bernard AE, et al. (2001) Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J. Clin. Invest. 108:1061-70.
39. Cappione AJ, Pugh-Bernard AE, Anolik JH, Sanz I. (2004) Lupus IgG VH4.34 antibodies bind to a 220-kDa glycoform of CD45/B220 on the surface of human B lymphocytes. J. Immunol. 172:4298-307.
40. Cocca BA, et al. (2001) Structural basis for autoantibody recognition of phosphatidylserinebeta 2 glycoprotein I and apoptotic cells. Proc. Natl. Acad. Sci. U. S. A. 98:13826-31.
41. Li Y, Li H, Ni D, Weigert M. (2002) Anti-DNA B cells in MRL/lpr mice show altered differentiation and editing pattern. J. Exp. Med. 196:1543-52.
42. Behrendt M, et al. (2003) The role of somatic mutation in determining the affinity of anti-DNA antibodies. Clin. Exp. Immunol. 131:182-9.
43. Muzio M, et al. (2008) Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy. Blood. 112:188-95.
44. Stevenson FK, Krysov S, Davies AJ, Steele AJ, Packham G. (2011) B-cell receptor signaling in chronic lymphocytic leukemia. Blood. 118:4313-20.
45. Silberstein LE, George A, Durdik JM, Kipps TJ. (1996) The V4-34 encoded anti-i autoantibodies recognize a large subset of human and mouse B-cells. Blood Cells Mol. Dis. 22:126-38.
46. Potter KN, Hobby P, Klijn S, Stevenson FK, Sutton BJ. (2002) Evidence for involvement of a hydrophobic patch in framework region 1 of human V4-34-encoded Igs in recognition of the red blood cell I antigen. J. Immunol. 169:3777-82.
47. Kostareli E, et al. (2009) Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors. Leukemia. 23:919-24.
48. Rossi D, et al. (2009) Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. Clin. Cancer Res. 15:4415-22.
49. Martin-Subero JI, et al. (2007) A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation. Leukemia. 21:1532-44.
50. Athanasiadou A, et al. (2008) Recurrent cytogenetic findings in subsets of patients with chronic lymphocytic leukemia expressing IgG-switched stereotyped immunoglobulins. Haematologica. 93:473-4.
51. Chapiro E, et al. (2008) The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemia. Leukemia. 22:2123-7.
52. Marincevic M, et al. (2010) High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors. Haematologica. 95:1519-25.
53. Rossi D, et al. (2013) Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia. Blood. 121:4902-5.
54. Gounari M, et al. (2012) Promiscuous antigen reactivity may underlie clinical aggressiveness and increased risk for Richter's syndrome in chronic lymphocytic leukemia with stereotyped IGHV4-39/ IGKV1(D)-39 B cell receptors. Oral session presented at: 54th ASH Annual Meeting and Exposition; 2012 Dec 8-11; Atlanta, GA ASH Abstract.
55. Ntoufa S, et al. (2012) Distinct innate immunity pathways to activation and tolerance in subgroups of chronic lymphocytic leukemia with distinct immunoglobulin receptors. Mol. Med. 18:1281-91.
56. Colombo M, et al. (2011) Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia. Mol. Med. 17:834-9.
57. Duty JA, et al. (2009) Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors. J. Exp. Med. 206:139-51.
58. Andrews SF, Wilson PC. (2010) The anergic B cell. Blood. 115:4976-8.